We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Tissue Cooling System Specifically Designed for Prostate Surgery

By HospiMedica International staff writers
Posted on 03 Dec 2008
A pelvic cooling catheter system has been designed to induce localized cooling during robotic-assisted prostatectomy, the most common surgical technique for prostate cancer. More...


The UroCool catheter system is designed to be placed within the rectal cavity adjacent to the prostate during surgery. The UroCool is used in conjunction with a control console, which circulates cold saline in a closed loop within the catheter to allow for localized cooling. The UroCool catheter system is being developed by InnerCool Therapies, the operating arm of Cardium Therapeutics (San Diego, CA, USA), and is being incorporated into ongoing clinical studies at the University of California Irvine (UCI; USA), which are designed to provide additional information regarding the safety and usefulness of the device pending submission for approval by the U.S. Food and Drug Administration (FDA).

"Our findings using localized cooling techniques during robotic-assisted radical prostatectomy surgery indicate that cooling resulted in a statistically significant faster recovery of urinary continence following surgery,” said Thomas E. Ahlering, M.D., professor and vice chair of the department of urology at UCI. "In addition, based on my surgical experience with therapeutic cooling, I believe that our ongoing studies may offer the potential to demonstrate improved post-operative erectile function for patients as well.”

"InnerCool has now developed a specialized tissue-specific cooling catheter that is being developed to work with InnerCool's current Celsius Control Console which has been marketed and sold since 2003,” added Christopher J. Reinhard, Chairman and CEO of Cardium Therapeutics and InnerCool Therapies. "The new UroCool system may provide an important opportunity to potentially enhance patient recovery of urinary control and erectile function following prostate surgery. These side effects of prostate surgery are serious, profound and frequent, and all too often patients defer proper surgical treatment because of these quality-of-life issues, underscoring the importance of new therapeutic approaches.”

Related Links:
Cardium Therapeutics
University of California Irvine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.